Dexamethasone, Neomycin, Thiabendazole
102 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
102
Total Reports
2
Deaths Reported
200.0%
Death Rate
Active Ingredients
Dexamethasone, Neomycin, Thiabendazole
Administration Routes
Auricular (Otic)OphthalmicTopicalUnknownOral
Species Affected
Dog 53
Cat 28
Human 18
Unknown 3
Most Affected Breeds
Domestic (unspecified) 22
Unknown 21
Crossbred Canine/dog 13
Poodle (unspecified) 7
Cat (unknown) 4
Maltese 3
Retriever - Labrador 3
Pug 3
Terrier - Yorkshire 2
Chihuahua 2
Most Reported Reactions
Accidental exposure 20
Deafness 19
Unclassifiable adverse event 18
Eye irritation 14
Anorexia 10
Eye pain 10
Pinnal irritation 9
Depression 8
Vomiting 5
Diarrhoea 5
Pinnal erythema 5
Elevated alanine aminotransferase (ALT) 5
Outcome Breakdown
Died
2 (100.0%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.